Ray H. Clark

441 total citations
14 papers, 346 citations indexed

About

Ray H. Clark is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ray H. Clark has authored 14 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ray H. Clark's work include Lung Cancer Treatments and Mutations (5 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). Ray H. Clark is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cancer Treatment and Pharmacology (3 papers). Ray H. Clark collaborates with scholars based in United States. Ray H. Clark's co-authors include Burton L. Baker, Chandra P. Belani, David Rinaldi, Glenn Mills, Sreenivasa Nattam, John Barstis, Michael C. Perry, Renato V. La Rocca, Donald R. Korst and B. L. Baker and has published in prestigious journals such as Science, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Ray H. Clark

14 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ray H. Clark United States	9	192	179	41	36	30	14	346
Jon Greenberg Germany	8	115 0.6×	72 0.4×	100 2.4×	13 0.4×	53 1.8×	14	330
U. Hacker-Klom Germany	13	46 0.2×	30 0.2×	107 2.6×	7 0.2×	30 1.0×	24	340
J.C. Calvo Spain	10	72 0.4×	31 0.2×	76 1.9×	15 0.4×	62 2.1×	15	322
Saara Lampelo Finland	11	94 0.5×	16 0.1×	84 2.0×	6 0.2×	22 0.7×	21	337
Nagesha Rao Netherlands	8	81 0.4×	60 0.3×	133 3.2×	9 0.3×	9 0.3×	8	326
Nicolás A. Fraunhoffer France	11	81 0.4×	33 0.2×	145 3.5×	23 0.6×	18 0.6×	38	347
Haim Hacham United States	8	41 0.2×	44 0.2×	124 3.0×	6 0.2×	6 0.2×	12	348
Louis Le United States	8	30 0.2×	69 0.4×	109 2.7×	20 0.6×	17 0.6×	8	335
Jan‐Gowth Chang Taiwan	14	90 0.5×	26 0.1×	258 6.3×	89 2.5×	52 1.7×	23	503
R. Paniagua Spain	13	47 0.2×	52 0.3×	165 4.0×	4 0.1×	111 3.7×	28	432

Countries citing papers authored by Ray H. Clark

Since Specialization

Citations

This map shows the geographic impact of Ray H. Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray H. Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray H. Clark more than expected).

Fields of papers citing papers by Ray H. Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ray H. Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray H. Clark. The network helps show where Ray H. Clark may publish in the future.

Co-authorship network of co-authors of Ray H. Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Ray H. Clark. A scholar is included among the top collaborators of Ray H. Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray H. Clark. Ray H. Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Belani, Chandra P., Shaker R. Dakhil, David Waterhouse, et al.. (2006). Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer. Annals of Oncology. 18(1). 110–115. 14 indexed citations

Ramalingam, Suresh S., John Barstis, Michael C. Perry, et al.. (2006). Treatment of Elderly Non–small Cell Lung Cancer Patients with Three Different Schedules of Weekly Paclitaxel in Combination with Carboplatin: Subanalysis of a Randomized Trial. Journal of Thoracic Oncology. 1(3). 240–244. 15 indexed citations

Belani, Chandra P., Suresh S. Ramalingam, John Barstis, et al.. (2003). P-252 Elderly patient subset analysis from the randomized trial of three different schedules of weekly paclitaxel in combination with carboplatin for advanced and metastatic non-small cell lung cancer (NSCLC). Lung Cancer. 41. S156–S156. 1 indexed citations

Belani, Chandra P., John Barstis, Michael C. Perry, et al.. (2003). Multicenter, Randomized Trial for Stage IIIB or IV Non–Small-Cell Lung Cancer Using Weekly Paclitaxel and Carboplatin Followed by Maintenance Weekly Paclitaxel or Observation. Journal of Clinical Oncology. 21(15). 2933–2939. 174 indexed citations

Clark, Ray H., et al.. (1989). A Phase II Trial of Intermittent Leukocyte Interferon and High Dose Chlorambucil in the Treatment of Non-Hodgkinʼs Lymphoma Resistant to Conventional Therapy. American Journal of Clinical Oncology. 12(1). 75–77. 9 indexed citations

Axelson, John A., Ray H. Clark, & Nikolay V. Dimitrov. (1987). cis-Platinum, 5-Fluorouracil, and Hydroxyurea in the Treatment of Advanced Non-Small-Cell Lung Cancer A Phase II Study. American Journal of Clinical Oncology. 10(3). 243–244. 2 indexed citations

Clark, Ray H., et al.. (1984). Leukocyte interferon as a possible biological response modifier in lymphoproliferative disorders resistant to standard therapy.. PubMed. 3(6). 613–9. 8 indexed citations

Clark, Ray H. & Donald R. Korst. (1969). Circadian Periodicity of Bone Marrow Mitotic Activity and Reticulocyte Counts in Rats and Mice. Science. 166(3902). 236–237. 43 indexed citations

Baker, Burton L. & Ray H. Clark. (1964). Response : "Circadian". Science. 145(3629). 296–296. 3 indexed citations

10.

Clark, Ray H. & Burton L. Baker. (1964). Circadian Periodicity in the Concentration of Prolactin in the Rat Hypophysis. Science. 143(3604). 375–376. 37 indexed citations

11.

Clark, Ray H. & Burton L. Baker. (1963). Effect of hypophysectomy on mitotic proliferation in gastric epithelium. American Journal of Physiology-Legacy Content. 204(6). 1018–1022. 19 indexed citations

12.

Baker, B. L., Ray H. Clark, & Robert L. Hunter. (1963). Starch Gel Electrophoresis of Rat Hypophysis in Relation to Prolactin Activity.. Experimental Biology and Medicine. 114(1). 251–255. 2 indexed citations

13.

Clark, Ray H. & B. L. Baker. (1962). Effect of Adrenalectomy on Mitotic Proliferation of Gastric Epithelium.. Experimental Biology and Medicine. 111(2). 311–315. 12 indexed citations

14.

Baker, B. L. & Ray H. Clark. (1961). Influence of Hypophysectomy on Oxidative Enzymes and Size of Parietal Cells in Gastric Mucosa.. Experimental Biology and Medicine. 106(1). 65–67. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact